A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder

Journal of Clinical Psychiatry

Volumn 66, Issue 8, 2005, Pages 997-1001

  Byerly, Matthew J ^a,b   Fisher, Robert ^a   Carmody, Thomas ^a   Rush, A John ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE THERAPY; COMPLIANCE THERAPY; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; MALE; MOTIVATION; OUTCOMES RESEARCH; OUTPATIENT; PATIENT EDUCATION; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

EID: 23944439105     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n0806     Document Type: Article

References (25)

1. Young JL, Zonana HV, Shepler L. Medication noncompliance in schizophrenia: codification and update. Bull Am Acad Psychiatry Law 1986;14:105-122
2. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997;23:637-651
3. Ayuso-Gutierrez JL, del Rio Vega JM. Factors influencing relapse in the long-term course of schizophrenia. Schizophr Res 1997;28:199-206
4. Steadman HJ, Mulvey EP, Monahan J, et al. Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods. Arch Gen Psychiatry 1998;55:393-401
5. Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull 1991;17:325-351
6. Lieberman JA, Sheitman B, Chakos M, et al. The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspective. J Clin Psychopharmacol 1998;18 (2Suppl 1):20S-24S
7. Olfson M, Mechanic D, Hansell S, et al. Predicting medication non-compliance after hospital discharge among patients with schizophrenia. Psychiatr Serv 2000;51:216-222
8. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull 1995;21:419-429
9. Kemp R, Hayward P, Applewhaite G, et al. Compliance therapy in psychotic patients: randomised controlled trial. BMJ 1996;312:345-349
10. Kemp R, Kirov G, Everitt B, et al. Randomised controlled trial of compliance therapy: 18-month follow-up. Br J Psychiatry 1998;172:413-419
11. Healey A, Knapp M, Astin J, et al. Cost-effectiveness evaluation of compliance therapy for people with psychosis. Br J Psychiatry 1998;172:420-424
12. O'Donnell C, Donohoe G, Sharkey L, et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ 2003;327:834
13. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999;21:1074-1090
14. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000;42:241-247
15. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276
16. David A, Buchanan A, Reed A, et al. The assessment of insight in psychosis. Br J Psychiatry 1992;161:599-602
17. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983;13:177-183
18. Miller W, Rollnick S. Motivational Interviewing: Preparing People to Change. New York, NY: Guilford Press; 1991
19. Kemp R, Hayward P, David A. Compliance Therapy Manual. London, UK: King's College School of Medicine and Dentistry and Institute of Psychiatry; 1997
20. Kemp R, Hayward P, David A. Understanding Compliance Therapy [videotape]. London, UK: King's College School of Medicine and Dentistry and Institute of Psychiatry; 1997
21. Miller WR, Rollnick S. Motivational Interviewing: Professional Training Videotape Series, 1998. Available at: http://www.motivationalinterview.org/ training/videos.html. Accessed Feb 2, 2005
22. Marks RG. Designing a Research Project. New York, NY: Van Nostrand Reinhold Co; 1982
23. Nose M, Barbui C, Tansella M. How often do patients with psychosis fail to adhere to treatment programmes? a systematic review. Psychol Med 2003;33:1149-1160
24. Byerly M, Fisher R, Rush AJ, et al. Comparison of clinician vs electronic monitoring of antipsychotic adherence in schizophrenia. Presented at the 156th annual meeting of the American Psychiatric Association; May 17-22, 2003; San Francisco, Calif
25. Diaz E, Levine HB, Sullivan MC, et al. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J Psychiatry Neurosci 2001;26:325-329